Target intelligence / Profile preview

Ribosomal protein L35a pseudogene 16 (RPL35AP16)

Target: RPL35AP16
Molecular classification: Other (Processed pseudogene; retrocopy of ribosomal protein gene)

Overview

RPL35AP16 is a processed pseudogene derived from ribosomal protein L35a (RPL35A)[3][8][10]. As a pseudogene, it does not encode a functional protein and has no known biological activity or disease relevance. It is identified only as a retrocopy of the parental ribosomal protein gene dispersed in the genome[8]. If a ribosomal protein target is required, the correct entity is “60S ribosomal protein L35a” (*RPL35A*)[1][5][9].

Other names: Ribosomal protein L35a pseudogene 16 (RPL35AP16)HGNC ID: 35485NCBI Gene ID: 100271318

Beyond the preview

Go deeper on Ribosomal protein L35a pseudogene 16 (RPL35AP16).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L35a pseudogene 16 (RPL35AP16).

Explore the full profile